Kashiwagi, S., Asano, Y., Goto, W., Takada, K., Takahashi, K., Noda, S., . . . Ohira, M. (2017). Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer. PLoS One.
Citação norma ChicagoKashiwagi, Shinichiro, et al. "Use of Tumor-infiltrating Lymphocytes (TILs) to Predict the Treatment Response to Eribulin Chemotherapy in Breast Cancer." PLoS One 2017.
ציטוט MLAKashiwagi, Shinichiro, et al. "Use of Tumor-infiltrating Lymphocytes (TILs) to Predict the Treatment Response to Eribulin Chemotherapy in Breast Cancer." PLoS One 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.